Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
npj Breast Cancer is Scopus-indexed (Q1, CiteScore 12.4), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by Nature Research.
Checked against the index lists dated .
ISSN 2374-4677Verify ISSN ↗
Publisher: Nature Research
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 13 / 361 | 96th | Q1 |
| Pharmacology (medical) | 15 / 278 | 94th | Q1 |
| Oncology | 39 / 428 | 91st | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q1, CiteScore 12.4.
npj Breast Cancer is Q1 in Radiology, Nuclear Medicine and Imaging (rank 13 of 361), Q1 in Pharmacology (medical) (rank 15 of 278) and Q1 in Oncology (rank 39 of 428), by CiteScore 2025.
npj Breast Cancer is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 12.4, which places it in quartile Q1 at the 96th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 3.554, quartile Q1, with an H-index of 63.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$3,790 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
npj Breast Cancer is published by Nature Research. Its ISSN is 2374-4677.
Yes. ONOS also covers its article processing charge for authors at eligible institutions.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
npj Breast Cancer has an h-index of 79 and a 2-year mean of 6.01 citations per paper (OpenAlex). Its Scopus CiteScore is 12.4, quartile Q1. On 2-year citations it ranks #13 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
npj Breast Cancer published 167 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from United States (38.3%), China (11.3%) and Brazil (4.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.